What is the market doing?
What the tape says about MLYS
Mineralys Therapeutics, Inc. is +101% over the past year while the S&P 500 is +23%: 79 points ahead of the market.
+101%
1-year return · S&P 500 +23%
- vs 200-day average
- −16%
vs 200-day average · a clear downtrend
- RSI (14)
- 42
RSI (14) · neutral
- Below its 52-week high
- −45%
Below its 52-week high
Details›
- Last close2026-08-26
- $25.88
- 1 monthS&P 500 +3.7%
- −4.1%
- 1 yearS&P 500 +23%
- +101%
- vs 50-day average$26.27
- −1.5%
- 52-week high
- $47.33
- 52-week low
- $13.00
- Annualised volatility
- 94%
- Insider buying, net, 6 monthsForms 3/4/5 to 2026-06-30
- $8.8M
| Year | Return |
|---|---|
| 2026 (year to date) | −29% |
| 2025 | +195% |
| 2024 | +43% |
| Month | Years | Positive | Average |
|---|---|---|---|
| Jan | 3 | 1 of 3 | −1.4% |
| Feb | 3 | 1 of 3 | +8.1% |
| Mar | 4 | 1 of 4 | +9.6% |
| Apr | 4 | 0 of 4 | −7.8% |
| May | 4 | 4 of 4 | +10% |
| Jun | 4 | 1 of 4 | −5.2% |
| Jul | 4 | 3 of 4 | −1.1% |
| Aug | 4 | 2 of 4 | −0.87% |
| Sep | 3 | 1 of 3 | +39% |
| Oct | 3 | 2 of 3 | −0.16% |
| Nov | 3 | 1 of 3 | −4.3% |
| Dec | 3 | 1 of 3 | +3.2% |
End-of-day closes from IEX; the S&P 500 comparison uses SPY over the same window. Prices are a reference point, not a basis for trading decisions.